Endeavor completes patient enrolment in trial of ENV-101
By A Mystery Man Writer
Description
Endeavor has concluded patient enrolment in a Phase IIa clinical trial of ENV-101 (taladegib) to treat idiopathic pulmonary fibrosis (IPF).
Endeavor completes patient enrolment in trial of ENV-101
Endeavor completes patient enrolment in trial of ENV-101
from
per adult (price varies by group size)